The role of endothelial dysfunction driven by adipocitokines in the development and progression of microvascular complications in patients with type 1 and type 2 diabetes

Medical Hypotheses
Kristina BlaslovLea Duvnjak

Abstract

Micro and macrovascular complications are the leading cause of morbidity and mortality in diabetic patients. During the last decades attention has been focused on their early diagnosis and prevention. Diabetes related metabolic abnormalities: insulin resistance, hyperglycaemia and dyslipidaemia along with oxidative stress and low-grade inflammation contribute to the development of endothelial dysfunction and macrovascular complications. Recent investigations indicate a potential role of adipocitokines originating from visceral adipose tissue: adiponectin, leptin, resistin and dipepetidyl peptidase-4 (DPP-4) activity in the development of microvascular complications in diabetes. The association of these adipocitokines with the activity of endothelial synthetase (eNOS) involved into the metabolism of nitric oxide (NO) was documented in animal and cell culture studies. We hypothesize that lower adiponectin and higher leptin and resistin plasma concentration and DPP-4 activity are associated with the development and progression of diabetic microvascular complications by endothelial function impairment. A possible identification of new markers of the complex pathophysiology development and progression of microvascular complications ...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jun 27, 2000·Diabetes Care·G UckayaI C Ozdemir
Jun 30, 2000·Biochemical and Biophysical Research Communications·K KimuraI Nishio
Sep 13, 2002·Obesity Research·Jerzy BeltowskiEwa Borkowska
Aug 29, 2003·The Journal of Biological Chemistry·Hui ChenMichael J Quon
Feb 10, 2004·Biochemical and Biophysical Research Communications·Hiroyuki MotoshimaBarry J Goldstein
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Erin E Kershaw, Jeffrey S Flier
Jul 14, 2004·European Journal of Endocrinology·Mahmut Ilker YilmazMetin Ozata
Nov 4, 2004·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·A SchäfflerB Zietz
Nov 27, 2004·Diabetes Research and Clinical Practice·M MatsudaK Kaku
Jun 29, 2005·Diabetes Care·Christophe E M De BlockLuc F Van Gaal
Oct 13, 2005·The Journal of Clinical Endocrinology and Metabolism·Casper G SchalkwijkUNKNOWN EURODIAB Prospective Complications Study Group
Feb 17, 2007·Biochemical and Biophysical Research Communications·Haruhiko OsawaHideichi Makino
Oct 9, 2007·Endothelium : Journal of Endothelial Cell Research·Yan LiQing Jia
Nov 24, 2007·Diabetes, Obesity & Metabolism·D TousoulisC Stefanadis
Feb 28, 2008·Journal of Korean Medical Science·Seon Mi JinYong Soo Yun
Apr 24, 2008·The Journal of Clinical Investigation·Kumar SharmaBarry J Goldstein
Aug 12, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Mykhaylo KordaTadeusz Malinski
Nov 26, 2008·Journal of Molecular and Cellular Cardiology·Yu CaoXin L Ma
May 4, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Changyi ChenQizhi Yao
Nov 25, 2011·Current Vascular Pharmacology·Dimitris TousoulisChristodoulos Stefanadis
Nov 25, 2011·Current Vascular Pharmacology·Dimitris TousoulisChristodoulos Stefanadis
Jan 8, 2013·The Medical Clinics of North America·Anne T Reutens
Aug 24, 2013·Journal of Diabetes and Its Complications·Anders JorsalPeter Rossing
Dec 3, 2013·Diabetes Research and Clinical Practice·UNKNOWN International Diabetes Federation
May 21, 2014·Journal of Diabetes Investigation·Ko HanaiYasuko Uchigata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.